| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.07 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |